JP2016210757A5 - - Google Patents

Download PDF

Info

Publication number
JP2016210757A5
JP2016210757A5 JP2015099519A JP2015099519A JP2016210757A5 JP 2016210757 A5 JP2016210757 A5 JP 2016210757A5 JP 2015099519 A JP2015099519 A JP 2015099519A JP 2015099519 A JP2015099519 A JP 2015099519A JP 2016210757 A5 JP2016210757 A5 JP 2016210757A5
Authority
JP
Japan
Prior art keywords
vitamin
bone strengthening
strengthening agent
agent according
isoflavone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015099519A
Other languages
Japanese (ja)
Other versions
JP2016210757A (en
Filing date
Publication date
Application filed filed Critical
Publication of JP2016210757A publication Critical patent/JP2016210757A/en
Publication of JP2016210757A5 publication Critical patent/JP2016210757A5/ja
Pending legal-status Critical Current

Links

Claims (5)

イソフラボンと、下記（ａ）〜（ｅ）からなる群より選ばれる少なくとも１種の成分とを有効成分として含有することを特徴とする骨強化剤。
（ａ）ケール、大麦、甘藷、長命草、松、ターミナリア、ココヤシ、及びマキベリーから選ばれる少なくとも１種の植物素材
（ｂ）ステアリン酸カルシウム及び還元麦芽糖から選ばれる少なくとも１種の添加剤
（ｃ）アスパラギン、システイン、グルタミン、グルタミン酸、グリシン、ロイシン、リシン、フェニルアラニン、セリン、及びバリンから選ばれる少なくとも１種のアミノ酸
（ｄ）クロロゲン酸
（ｅ）ビタミンＢ１、ビタミンＢ２、ビタミンＢ６、ビタミンＢ１２、パントテン酸ナトリウム、ナイアシン、葉酸、ビタミンＫ、マグネシウム、鉄、セレン、及びカルシウムから選ばれる少なくとも１種のビタミン・ミネラル類 A bone strengthening agent comprising isoflavone and at least one component selected from the group consisting of the following (a) to (e) as active ingredients.
(A) at least one plant material selected from kale, barley, sweet potato, long life grass, pine, terminaria, coconut , and maquiberry (b) at least one additive selected from calcium stearate and reduced maltose (c) asparagine Cysteine, glutamine, glutamic acid, glycine, leucine, lysine, phenylalanine, serine and valine (d) chlorogenic acid (e) vitamin B1, vitamin B2, vitamin B6, vitamin B12, sodium pantothenate At least one vitamin / mineral selected from niacin, folic acid, vitamin K, magnesium, iron, selenium, and calcium イソフラボンと（ａ）〜（ｅ）からなる群より選ばれる少なくとも１種の成分とからなる有効成分を添加して得たことを特徴とする請求項１記載の骨強化剤。   The bone strengthening agent according to claim 1, obtained by adding an active ingredient comprising isoflavone and at least one component selected from the group consisting of (a) to (e). イソフラボン及び他の有効成分の配合質量比が、０．５：１〜７０：１の範囲であることを特徴とする請求項１又は２記載の骨強化剤。   The bone strengthening agent according to claim 1 or 2, wherein the blending mass ratio of isoflavone and other active ingredients is in the range of 0.5: 1 to 70: 1. 錠剤、カプセル剤、粉末剤、顆粒剤、又は液剤であることを特徴とする請求項１〜３のいずれか記載の骨強化剤。   The bone strengthening agent according to any one of claims 1 to 3, which is a tablet, capsule, powder, granule, or liquid. 請求項１〜４のいずれか記載の骨強化剤を摂取させることを特徴とする骨強化方法（ただし、医療行為を除く）。   A bone strengthening method (excluding medical practice), characterized in that the bone strengthening agent according to any one of claims 1 to 4 is ingested.
JP2015099519A 2015-04-30 2015-05-14 Bone fortifier dietary supplements Pending JP2016210757A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015093652 2015-04-30
JP2015093652 2015-04-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019085649A Division JP2019122411A (en) 2015-04-30 2019-04-26 Bone fortifier dietary supplements

Publications (2)

Publication Number Publication Date
JP2016210757A JP2016210757A (en) 2016-12-15
JP2016210757A5 true JP2016210757A5 (en) 2019-03-14

Family

ID=57551213

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015099519A Pending JP2016210757A (en) 2015-04-30 2015-05-14 Bone fortifier dietary supplements
JP2019085649A Pending JP2019122411A (en) 2015-04-30 2019-04-26 Bone fortifier dietary supplements
JP2020098029A Pending JP2020128436A (en) 2015-04-30 2020-06-04 Bone fortifier dietary supplements
JP2022028773A Pending JP2022060571A (en) 2015-04-30 2022-02-28 Bone fortifier dietary supplements
JP2023197909A Pending JP2024009190A (en) 2015-04-30 2023-11-22 Bone fortifier dietary supplements

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2019085649A Pending JP2019122411A (en) 2015-04-30 2019-04-26 Bone fortifier dietary supplements
JP2020098029A Pending JP2020128436A (en) 2015-04-30 2020-06-04 Bone fortifier dietary supplements
JP2022028773A Pending JP2022060571A (en) 2015-04-30 2022-02-28 Bone fortifier dietary supplements
JP2023197909A Pending JP2024009190A (en) 2015-04-30 2023-11-22 Bone fortifier dietary supplements

Country Status (1)

Country Link
JP (5) JP2016210757A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7397563B2 (en) * 2016-12-28 2023-12-13 小林製薬株式会社 solid preparation
JP6742608B2 (en) * 2018-03-30 2020-08-19 株式会社東洋新薬 Food composition
EP3701960A1 (en) * 2019-02-27 2020-09-02 Anklam Extrakt GmbH Maqui berry extracts for use in the treatment or prevention of bone disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3089460B2 (en) * 1995-12-20 2000-09-18 株式会社アルソア本社 Healthy tea
JP4532811B2 (en) * 2002-03-20 2010-08-25 株式会社ファンケル Female hormone-like agent
JP2004033092A (en) * 2002-07-02 2004-02-05 Aomori Prefecture Method for ameliorating harsh taste of vegetable estrogen derivative, natto or natto food using the method and method for producing the same
JP2005137210A (en) * 2003-11-04 2005-06-02 Hino Shokai:Kk Composition comprising concoction of tea and peucedanum japonicum thunb. or extract from the concoction
JP2007099664A (en) * 2005-10-04 2007-04-19 Toyo Shinyaku:Kk Bone resorption inhibitor
JP6182808B2 (en) * 2013-08-14 2017-08-23 リプロバイオ株式会社 Sperm improving agent and semen improving agent containing button bow fu or its extract

Similar Documents

Publication Publication Date Title
PH12018502268A1 (en) Amide-substituted pyridinyltriazole derivatives and uses thereof
MX2022014313A (en) Formulations for oral administration of active agents with controlled absorption profile.
MX2020002271A (en) Pharmaceutical compositions comprising sepiapterin and uses thereof.
JP2009531457A5 (en)
WO2017218981A3 (en) Compositions and methods for reducing ocular neovascularization
PH12020550341A1 (en) Niraparib formulations
PH12019500815A1 (en) Extract of an herbal composition as antimicrobial and/or antibiofilm agent
WO2019023039A3 (en) Compositions for enhancing bioavailability of pharmaceuticals, supplements and ingested substances
WO2016142708A3 (en) Pharmaceutical composition
JP2015131825A5 (en)
JP2016210757A5 (en)
MX2020000577A (en) Powdered formulations of cromolyn sodium and ibuprofen.
MX2019001850A (en) Formulations for oral administration of active agents.
PH12017500320B1 (en) Pharmaceutical composition comprising gold-containing agent for preventing or treating liver fibrosis or liver cirrhosis
MX2019005775A (en) Pharmaceutical parenteral formulation containing carglumic acid.
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
JP2017012144A5 (en)
JP2017014155A5 (en)
WO2016076607A3 (en) Pharmaceutical composition and health functional food, containing a red ginseng concentrate with enriched compound k component, for preventing and treating non-alcoholic fatty liver symptom
JP2017008001A5 (en)
EA201892842A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING SAFINAMID
MX2015012771A (en) Method of treating vitamin b12 deficiency.
JP2017002009A5 (en)
HRP20190676T1 (en) Composition for the prevention or treatment of polycystic ovary syndrome and its related symptoms
JP2017014164A5 (en)